Artificial Intelligence (AI) in Nanotech Pharmacology: Revolutionizing Drug Development

Abstract

Artificial intelligence (AI) is revolutionizing healthcare by significantly enhancing the early detection, diagnosis, treatment, and prediction of disease outcomes. This chapter explores AI’s transformative impact on healthcare settings, highlighting key applications that have improved patient outcomes and healthcare efficiency. We delve into the fundamentals of machine learning (ML), a critical foundation of AI, covering its three primary learning modes: supervised, unsupervised, and reinforcement learning. This chapter also identifies common issues in ML models, such as overfitting and underfitting, and discusses strategies for mitigation. Furthermore, we examine various types of predictions in ML, including classification, regression, and clustering, offering real-world examples of problems best suited to each approach. The training and evaluation of ML models are also explored, emphasizing the importance of dividing data into training, validation, and testing sets, along with key parameters like learning rate and K-fold cross-validation. Common ML algorithms, including decision trees, k-nearest neighbors, support vector machines, and deep learning, are examined in terms of their applications, strengths, and limitations. In the context of medical applications, we analyze the unique challenges of ML in healthcare, including issues with data limitations, sampling bias, and model interpretability. The course further explores the use of AI in nanomedicine, where it aids in designing, predicting the effectiveness of, and assessing the potential toxicity of nanomedicine. Finally, the role of AI in improving clinical trial success rates and streamlining healthcare documentation processes, such as reducing chart-writing time, is also discussed. Through this comprehensive exploration, learners will gain a deep understanding of how AI and ML are shaping the future of healthcare.

Ähnliche Arbeiten